IPSEN (IPSEY)
(Delayed Data from OTC)
$31.17 USD
+0.81 (2.67%)
Updated Nov 1, 2024 11:40 AM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Income Statements
Fiscal Year end for IPSEN falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3,579 | 3,326 | 3,548 | 3,068 | 3,016 |
Cost Of Goods | 618 | 556 | 637 | 560 | 547 |
Gross Profit | 2,960 | 2,770 | 2,912 | 2,508 | 2,469 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,077 | 2,000 | 1,907 | 1,913 | 2,507 |
Income After Depreciation & Amortization | 883 | 769 | 1,005 | 595 | -37 |
Non-Operating Income | -38 | -6 | -13 | 40 | 28 |
Interest Expense | 21 | 19 | 28 | 31 | 34 |
Pretax Income | 824 | 744 | 964 | 604 | -43 |
Income Taxes | 147 | 118 | 199 | -20 | 22 |
Minority Interest | 3 | -1 | 0 | 1 | 1 |
Investment Gains/Losses | -6 | -2 | 0 | -2 | 4 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 671 | 624 | 765 | 623 | -61 |
Extras & Discontinued Operations | 30 | 58 | 0 | 4 | 5 |
Net Income (GAAP) | 697 | 683 | 765 | 626 | -57 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 978 | 1,124 | 1,285 | 863 | 143 |
Depreciation & Amortization (Cash Flow) | 95 | 355 | 280 | 268 | 181 |
Income After Depreciation & Amortization | 883 | 769 | 1,005 | 595 | -37 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 333.45 | 332.19 | 333.30 | 333.64 | 332.46 |
Diluted EPS Before Non-Recurring Items | 2.48 | 2.77 | 2.69 | 2.09 | 1.89 |
Diluted Net EPS (GAAP) | 2.09 | 2.06 | 2.30 | 1.88 | -0.17 |
Fiscal Year end for IPSEN falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |